Â鶹´«Ã½

Session II

Senate

Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• May 23, 2024Ìý—ÌýFY 2025 Budget Request for the National Institutes of Health
  • Written Statement of Monica M. Bertagnolli, Director, NIH

House

Committee on Oversight and Accountability — Select Subcommittee on the Coronavirus Pandemic

• May 16, 2024Ìý—ÌýOverseeing the Overseers: A Hearing with Â鶹´«Ã½ Deputy director, Dr. Lawrence Tabak
  • Written Statement of Lawrence Tabak, Principal Deputy Director, NIH

Committee on Science, Space and Technology

• February 15, 2024 — Examining Federal Science Agency Actions to Secure the U.S. Science and Technology Enterprise
  • Written Statement of Michael Lauer, Deputy Director for Extramural Research

Session I

Senate

Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related AgenciesSS

• July 11, 2023Ìý—ÌýAccelerating Breakthroughs: How the Special Diabetes Program Is Creating Hope for those Living with Type 1 Diabetes
  • Written Statement of Griffin P. Rodgers, Director, NIDDK

Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• May 4, 2023 — President's FY 2024 Funding Request and Budget Justification for the National Institutes of Health
  • Written Statement of Lawrence Tabak, Performing the Duties of the Director, NIH

House

Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• April 19, 2023Ìý—ÌýFY 2024 Budget Request for the National Institutes of Health, Centers for Disease Control and Prevention, and the Administration for Strategic Preparedness and Response

Committee on Energy and Commerce, Subcommittee on Health and Oversight and Investigations

• February 8, 2023 — The Federal Response to COVID-19
  • Written Statement of Lawrence Tabak, Performing the Duties of the Director, NIH

Session I

Senate

Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• May 26, 2021 — National Institutes of Health’s FY 2022 Budget and the State of Medical Research
  • Written Statement of Francis Collins, Director, NIH

Committee on Health, Education, Labor, and Pensions

• March 18, 2021 — Examining our COVID-19 Response: An Update from Federal Officials
  • Written Statement of Anthony Fauci, Director, NIAID
• April 22, 2021 — Protecting U.S. Biomedical Research: Efforts to Prevent Undue Foreign Influence
  • Written Statement of Michael Lauer, Deputy Director for Extramural Research
• May 11, 2021 — An Update from Federal Officials on Efforts to Combat COVID-19
  • Written Statement of Anthony Fauci, Director, NIAID
• July 20, 2021 — The Path Forward: A Federal Perspective on the COVID-19 Response
  • Written Statement of Anthony Fauci, Director, NIAID
• November 4, 2021 — Next Steps: The Road Ahead for the COVID-19 Response
  • Written Statement of Anthony Fauci, Director, NIAID

ÌýCaucus on International Narcotics Control

• July 20, 2021 — The Federal Responses to the Drug Overdose Epidemic
  • Written Statement of Nora Volkow, Director, NIDA

House

Committee on Energy and Commerce —Subcommittee on Health

• July 29, 2021Ìý—ÌýThe Path Forward: Advancing Treatments and Cures for Neurodegenerative Diseases
  • Written Statement of Walter Koroshetz, Director, NINDS
  • Written Statement of Richard Hodes, Director, NIA

Committee on AppropriationsÌý—ÌýSubcommittee on Labor Health and Human Services, Education, and Related Agencies

• May 25, 2021 — FY 2022 Budget Request for the National Institutes of Health
  • Written Statement of Francis Collins, Director, NIH

Committee on Energy and Commerce, Subcommittee on Oversight and Investigations

• March 17, 2021 — Leading the Way Forward: Biden Administration Actions to Increase COVID-19 Vaccinations
  • Written Statement of Anthony Fauci, Director, NIAID

Committee on Energy and CommerceÌý—ÌýSubcommittee on Health

• April 28, 2021 — The Long Haul: Forging a Path Through the Lingering Effects of COVID-19
  • Written Statement of Francis Collins, Director, NIH
• July 29, 2021- The Path Forward: Advancing Treatments and Cures for Neurodegenerative Diseases
  • Written Statement of Richard Hodes, Director, NIA and Walter Koroshetz, Director, NINDS
• December 2, 2021 — The Overdose Crisis: Interagency Proposal to Combat Illicit Fentanyl-Related Substances
  • Written Statement of Nora Volkow, Director, NIDA

Select Subcommittee on the Coronavirus Crisis

• April 15, 2021 — Reaching the Light at the End of the Tunnel: A Science-Driven Approach to Swiftly Ending the Pandemic
  • Written Statement of Anthony Fauci, Director, NIAID

Session II

Senate

Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• May 17, 2022 — FY 2023 Budget Request for the National Institutes of Health
  • Written Statement for Lawrence Tabak, Acting Director, NIH

Committee on Health, Education, Labor, and Pensions

• January 11, 2022 — Addressing New Variants: A Federal Perspective on the COVID-19 Response
  • Written Statement of Anthony Fauci, Director, NIAID
• March 23, 2022 — Strengthening Federal Mental Health and Substance Use Disorder Programs: Opportunities, Challenges, and Emerging Issues
  • Written Statement of Joshua Gordon, Director, NIMH
  • Written Statement of Nora Volkow, Director, NIDA
• June 16, 2022 — An Update on the Ongoing Federal Response to COVID-19: Current Status and Future Planning
  • Written Statement of Anthony Fauci, Director, NIAID
• September 14, 2022 — Stopping the Spread of Monkeypox: Examining the Federal Response
  • Written Statement of Anthony Fauci, Director, NIAID

House

Committee on AppropriationsÌý—ÌýSubcommittee on Labor Health and Human Services, Education, and Related Agencies

• May 11, 2022 — FY 2023 Budget Request for the National Institutes of Health
  • Written Statement for Lawrence Tabak, Acting Director, NIH

Session I

Senate

Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• March 14, 2019 — Review of the Ebola outbreak in the Democratic Republic of the Congo and Other Emerging Health Threats
  • Written Statement of Anthony Fauci, Director, NIAID
• April 11, 2019 — FY 2020 National Institutes of Health Budget Request
  • Written Statement of Francis Collins, Director, NIH

Committee on Aging

• April 2, 2019 — Alzheimer’s: New Directions in Biomedical Research and Caregiving
  • Written Statement of Richard Hodes, Director, NIA
• July 10, 2019 — Redefining Reality: How the Special Diabetes Program is Changing the Lives of Americans with Type 1 Diabetes
  • Written Statement of Griffin Rodgers, Director, NIDDK

Committee on Environment and Public Works

• March 28, 2019 — Examining the Federal response to the risks associated with per- and polyfluoroalkyl substances (PFAS)
  • Written Statement of Linda Birnbaum, Director, NIEHS

Committee on Finance

• June 5, 2019 — Foreign Threats to Taxpayer Funded Research: Oversight Opportunities and Policy Solutions
  • Written Statement of Lawrence Tabak, Principal Deputy Director, NIH

Committee on Homeland Security and Governmental Affairs — Permanent Subcommittee on Investigation

• November 19, 2019 — Securing the U.S. Research Enterprise from China’s Talent Recruitment Plans
  • Written Statement of Michael Lauer, Deputy Director for Extramural Research

Caucus on International Narcotics Control

• October 23, 2019 — Marijuana and America’s Health: Questions and Issues for Policy Makers
  • Written Statement of Jerome Adams, U.S. Surgeon General and Nora Volkow, Director, NIDA

House

Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• April 2, 2019 — FY 2020 National Institutes of Health Budget Request
  • Written Statement of Francis Collins, Director, NIH
• September 25, 2019 — Investments in Medical Research at Five Institutes and Centers of the National Institutes of Health
  • Written Statement of Francis Collins, Director, NIH
  • Written Statement of Christopher Austin, Director, NCATS
  • Written Statement of Patricia Brennan, Director, NLM
  • Written Statement of Helene Langevin, Director, NCCIH
  • Written Statement of Eliseo Perez-Stable, Director, NIMHD
  • Written Statement of Bruce Tromberg, Director, NIBIB

Committee on Energy and CommerceÌý—ÌýSubcommittee on Oversight and Investigations

• February 27, 2019 — Measles: The Continued Re-emergence of a Vaccine-Preventable Disease
  • Written Statement of Anthony Fauci, Director, NIAID
• December 4, 2019 — Flu Season: U.S. Public Health Preparedness and Response
  • Written Statement of Anthony Fauci, Director, NIAID

Committee on Science, Space, and Technology

• November 20, 2019 — Fighting Flu, Saving Lives: Vaccine Science and Innovation
  • Written Statement of Anthony Fauci, Director, NIAID

Committee on Veteran Affairs

• April 29, 2019 — Tragic Trends: Suicide Prevention Among Veterans
  • Written Statement of Shelli Avenevoli, Deputy Director, NIMH

Session II

Senate

Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• July 2, 2020 — Review of Operation Warp Speed: Researching, Manufacturing, & Distributing a Safe & Effective Coronavirus Vaccine
  • Written Statement of Francis Collins, Director, NIH

Committee on Health, Education, Labor, and Pensions

• March 3, 2020 — Emerging Disease Threat: How the U.S. Is Responding to COVID-19, the Novel Coronavirus
  • Written Statement of Anthony Fauci, Director, NIAID
• May 7, 2020 — Shark Tank: New Tests for COVID-19
  • Written Statement of Francis Collins, Director, NIH
• May 12, 2020 — COVID-19: Safely Getting Back to Work and Back to School
  • Written Statement of Anthony Fauci, Director, NIAID
• June 30, 2020 — COVID-19: Update on Progress Toward Safely Getting Back to Work and Back to School
  • Written Statement of Anthony Fauci, Director, NIAID
• September 9, 2020 — Vaccines: Saving Lives, Ensuring Confidence, and Protecting Public Health
  • Written Statement of Francis Collins, Director, NIH
• September 23, 2020 — COVID-19: An Update on the Federal Response
  • Written Statement of Anthony Fauci, Director, NIAID

House

Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• March 4, 2020 — FY 2021 National Institutes of Health Budget Request
  • Written Statement of Francis Collins, Director, NIH

Committee on Energy and Commerce

• June 23, 2020 — Oversight of the Trump Administration's Response to the COVID-19 Pandemic
  • Written Statement of Anthony Fauci, Director, NIAID

Committee on Energy and CommerceÌý—ÌýSubcommittee on Health

• January 15, 2020 — Cannabis Policies for the New Decade
  • Written Statement of Nora Volkow, Director, NIDA
• February 26, 2020 — The Fiscal Year 2021 HHS Budget and Oversight of the Coronavirus Outbreak

Committee on Oversight and Reform

• March 11, 2020 — Coronavirus Preparedness and Response
  • Written Statement of Anthony Fauci, Director, NIAID

Select Subcommittee on the Coronavirus Crisis

• July 31, 2020 — The Urgent Need for a National Plan to Contain the Coronavirus
  • Written Statement of Anthony Fauci, Director, NIAID

Session I

Senate

Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• June 22, 2017 — FY2018 Budget Request for the National Institutes of Health
  • Written Statement of Francis Collins, Director, NIH

House

Committee on AppropriationsÌý—ÌýSubcommittee on Labor, Health and Human Services, Education, and Related Agencies

• May 17, 2017 — Advances in Biomedical Research
  • Written Statement of Francis Collins, Director, NIH

Committee on Energy and CommerceÌý—ÌýSubcommittee on Oversight and Investigations

• March 21, 2017 — Fentanyl: The Next Wave of the Opioid Crisis
  • Written Statement of Wilson Compton, Deputy Director, NIDA
• May 23, 2017 — U.S. Public Health Response to the Zika Virus: Continuing Challenges
  • Written Statement of Anthony Fauci, Director, NIAID

Session II

Senate

Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• May 17, 2018 — FY 2019 National Institutes of Health Budget Request
  • Written Statement of Francis Collins, Director, NIH

Committee on Health, Education, Labor, and Pensions

• August 23, 2018 — Prioritizing Cures: Science and Stewardship at the National Institutes of Health
  • Written Statement of Francis Collins, Director, NIH

Committee on Homeland Security and Governmental AffairsÌý—ÌýSubcommittee on Federal Oversight and Emergency Management

• September 26, 2018 — The Federal Role in the Toxic PFAS Chemical Crisis
  • Written Statement of Linda Birnbaum, Director, NIEHS

House

Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• April 11, 2018 — FY 2019 National Institutes of Health Budget Request
  • Written Statement of Francis Collins, Director, NIH
• April 18, 2018 — FY19 Health and Human Services Biodefense Activities
  • Written Statement of Anthony Fauci, Director, NIAID

Committee on Energy and CommerceÌý—ÌýSubcommittee on Health

• July 25, 2018 — 21st Century Cures Implementation: Updates from FDA and NIH
  • Written Statement of Francis Collins, Director, NIH

Committee on Energy and CommerceÌý—ÌýSubcommittee on Oversight and Investigations

• March 8, 2018Ìý—ÌýExamining U.S. Public Health Preparedness for and Response Efforts to Seasonal Influenza
  • Written Statement of Anthony Fauci, Director, NIAID

Session I

Senate

Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• April 30, 2015 — FY 2016 Budget Request for NIH
  • Written Statement for Francis Collins, Director, NIH
• October 7, 2015 — The NIH: Investing in a Healthier Future
  • Written Statement for Francis Collins, Director, NIH

Committee on Health, Education Labor and Pensions

• March 10, 2015 — US Medical Innovation
  • Written Statement for Francis Collins, Director, NIH

• April 28, 2015 — Medical Innovation for Patients
  • Written Statement for Christopher Austin, Director, NCATS
  • Written Statement for Roderic Pettigrew, Director, NIBIB
• May 5, 2015 — Precision Medicine
  • Written Statement for Francis Collins, Director, NIH

• October 29, 2015 — Mental Health Issues
  • Written Statement for Thomas Insel, Director, NIMH

Committee on Special Aging

• March 25, 2015 — Alzheimer’s Disease
  • Written Statement for Richard Hodes, Director, NIA

House

Committee on AppropriationsÌý—ÌýSubcommittee on Labor Health and Human Services, Education, and Related Agencies

• March 3, 2015 — FY 2016 Budget Request for NIH
  • Written Statement for Francis Collins, Director, NIH

• April 15, 2015 — Ebola
  • Written Statement for Anthony Fauci, Director, NIAID

Committee on Energy and Commerce, Subcommittee on Health

• April 30, 2015 — 21st Century Cures Bill
  • Written Statement for Kathy Hudson, Deputy Director for Science, Outreach, and Policy

Committee on Energy and CommerceÌý—ÌýSubcommittee on Oversight and Investigations

• February 3, 2015 — The U.S. Public Health Response to Seasonal Influenza
  • Written Statement for Anthony Fauci, Director, NIAID

• May 1, 2015 — Opioid Abuse
  • Written Statement for Nora Volkow, Director, NIDA
• November 19, 2015 — Flu Preparedness
  • Written Statement for Carole Heilman, Director, Division of Microbiology and Infectious Diseases, NIAID

Session II

Senate

Senate Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• April 7, 2016 — Fiscal Year 2017 Budget Request
  • Written Statement for Francis Collins, Director, NIH

Senate Committee on Health, Education, Labor, and Pensions Committee

• February 24, 2016 — Research Conducted and Supported by the National Institutes of Health (NIH) in Addressing Zika Virus Disease
  • Written Statement for Anthony Fauci, Director, NIAID

Senate Committee on Labor, Health and Human Services, Education, and Related Agencies

• February 11, 2016 — Research Conducted and Supported by the National Institutes of Health (NIH) in Addressing Emerging and Re-emerging Infectious Diseases Including Zika Virus Disease
  • Written Statement for Anthony Fauci, Director, NIAID

House

House Committee on Energy and CommerceÌý—ÌýSubcommittee on Oversight and Investigations

• March 2, 2016 — Research Conducted and Supported by the National Institutes of Health (NIH) in Addressing Zika Virus Disease
  • Written Statement for Anthony Fauci, Director, NIAID

• April 20, 2016 — Laboratory Safety ar Â鶹´«Ã½
  • Written Statement for Lawrence Tabak, Deputy Director, NIH

• June 14, 2016 — The Role of the National Institute of Allergy and Infectious Diseases Research in Combating Antibiotic Resistance
  • Written Statement for Dennis Dixon, Chief, Bacteriology and Mycology Branch, NIAID

• September 27, 2016 — Lab Safety and Inactivation of Microbiological Agents ar Â鶹´«Ã½
  • Written Statement for Jeffrey Potts, Biorisk Manager, NIH

House Committee on Foreign AffairsÌý—ÌýSubcommittee on Africa, Global Health, Global Human Rights, and International Organizations and Subcommittee on the western Hemisphere

• February 10, 2016 — Zika Virus Disease
  • Written Statement for Anthony Fauci, Director, NIAID

House Committee on Labor, Health and Human Services, Education, and Related Agencies

• March 16, 2016 — Fiscal Year 2017 Budget Request
  • Written Statement for Francis Collins, Director, NIH

House Committee on Oversight and Government Reform

• February 24, 2016 — Research Conducted and Supported by the National Institutes of Health (NIH) in Addressing Zika Virus Disease
  • Written Statement for Anthony Fauci, Director, NIAID

House Committee on Science, Space, and Technology, Subcommittee on Research & Technology

• June 16, 2016 — SBIR/STTR Reauthorization: A Review of Technology Transfer
  • Written Statement for Michael Lauer, Deputy Director for Extramural Research

House Committee on Small Business

• March 2, 2016 — Commercializing on Innovation: Reauthorizing the Small Business Innovation Research and Small Business Technology Transfer Program
  • Written Statement for Matthew Portnoy, Director, Division of Special Programs

House Democratic Steering and Policy Committee

• May 12, 2016 — Research Conducted and Supported by the National Institutes of Health (NIH) in Addressing Zika Virus Disease
  • Written Statement for Anthony Fauci, Director, NIAID

Session I

Senate

Committee on AppropriationsÌý—ÌýSubcommittee on Labor, HHS, and Education

• May 15, 2013 — Fiscal Year 2014 Budget Request for NIH
  • Written Statement for Dr. Francis Collins, Â鶹´«Ã½ Director
  • Written Statement for Dr. Anthony Fauci, NIAID Director
  • Written Statement for Dr. Gary Gibbons, NHLBI Director
  • Written Statement for Dr. Richard Hodes, NIA Director
  • Written Statement for Dr. Story Landis, NINDS Director
  • Written Statement for Dr. Harold Varmus, NCI Director

Committee on Health, Education, Labor, and Pensions

• January 24, 2013 — Assessing the State of America’s Mental Health System
  • Written Statement for Dr. Thomas Insel, NIMH Director

House

Committee on AppropriationsÌý—ÌýSubcommittee on Labor, HHS, and Education

• March 5, 2013 — Fiscal Year 2014 Budget Request for NIH
  • Written Statement for Dr. Francis Collins, Â鶹´«Ã½ Director

Session II

Senate

Committee on Appropriations

• April 29, 2014 — Federal Investments in Innovation
  • Written Statement for Dr. Francis Collins, Â鶹´«Ã½ Director

Committee on Appropriations — Subcommittee on Labor, HHS, and Education

• September 16, 2014 — The Ebola Threat in West Africa
  • Written Statement for Dr. Anthony Fauci, Director, NIAID

• April 2, 2014 — Fiscal Year 205 Budget Request for NIH
  • Written Statement for Dr. Francis Collins, Director, NIH
• February 27, 2014 — PHEMCE
  • Written Statement for Dr. Michael Kurilla, Associate Director for Biodefense Product Development, NIAID
• February 26, 2014 — Alzheimer’s Disease
  • Written Statement for Dr. Francis Collins, Director, NIH

Committee on Special Aging

• June 25, 2014 — Brain Injuries and Diseases of Aging
  • Written Statement for Dr. Walter Koroshetz, Deputy Director, NINDS

• May 7, 2014 — Cancer Challenges
  • Written Statement for Dr. Harold Varmus, Director, NCI

Committee on Veteran’s Affairs

• April 30, 2014 — Veterans and Overmedication
  • Written Statement for Dr. Josephine Briggs, Director, NCCAM

Caucus on International Narcotics Control

• May 14, 2014 — America’s Addiction to Opioids: Heroin and Prescription Drug Abuse
  • Written Statement for Dr. Nora Volkow, Director, NIDA

House

Committee on Appropriations — Subcommittee on Labor, HHS, and Education

• March 26, 2014 — Future of Biomedical Research
  • Written Statement for Dr. Francis Collins, Director, NIH

Committee on Energy and Commerce — Subcommittee on Health

• November 19, 2014 — Medical Product Development After Ebola
  • Written Statement for Dr. Anthony Fauci, Director, NIAID

Committee on Energy and Commerce — Subcommittee on Oversight and Investigation

• October 16, 2014 — Ebola Prevention and Response Efforts
  • Written Statement for Dr. Anthony Fauci, Director, NIAID

• April 29, 2014 — Prescription Drug and Heroin Abuse
  • Written Statement for Dr. Nora Volkow, Director, NIDA

Committee on Foreign Affairs — Subcommittee on Africa, Global Health, Global Human Rights and International Organization

• September 17, 2014 — Global Efforts to Fight Ebola
  • Written Statement for Dr. Anthony Fauci, Director, NIAID

Committee on Science, Space and Technology — Subcommittee on Research and Technology

• July 17, 2014 — Innovative Medical Achievements
  • Written Statement for Dr. Harold Varmus, Director, NCI

Committee on Small Business

• July 23, 2014 — Small Business Innovation Research and Small Business Technology Transfer Programs
  • Written Statement for Matthew Portnoy, Director, Division of Special Programs, Manager, National Institutes of Health SBIR/STTR Program

Committee on Oversight and Government Reform — Subcommittee on Government Operations

• June 20, 2014 — The Adverse Health Effects of Marijuana Use
  • Written Statement for Dr. Nora Volkow, Director, NIDA

• May 20, 2014 — The Federal Government’s Response to Autism
  • Written Statement for Dr. Thomas Insel, Director, NIMH

• May 14, 2014 — America’s Addiction to Opioids: Heroin and Prescription Drug Abuse
  • Written Statement for Dr. Nora Volkow, Director, NIDA

Session I

Senate

Committee on AppropriationsÌý—Ìý​Subcommittee on Labor, HHS, and Education

• May 11, 2011 — Fiscal Year 2012 Budget Request for NIH
  • Written Statement for Dr. Francis Collins, Â鶹´«Ã½ Director

Committee on Environmental and Public Works

• February 2, 2011 — Drinking Water Contaminants
  • Written Statement for Dr. Linda Birnbaum, NIEHS Director

Committee on Homeland Security and Government Affairs

• June 22, 2011 — Transforming Lives Through Diabetes Research
  • Written Statement for Dr. Griffin Rodgers, NIDDK Director

House

Committee on Energy and CommerceÌý—ÌýSubcommittee on Health

• July 11, 2011 — Legislative Hearing on Various Bills (including the Combating Autism Reauthorization Act)
  • Written Statement for Dr. Thomas Insel, NIMH Director

Committee on Foreign Affairs-Subcommittee on Africa, Global Health, and Human Rights

• June 23, 2011 — Global Strategies to Combat Alzheimer’s Disease
  • Written Statement for Dr. Richard Hodes, NIA Director

Committee on Science, Space, and Technology-Subcommittee on Technology and Innovation

• March 31, 2011 — The Role of Small Business in Innovation and Job Creation: The SBIR/STTR Programs
  • Written Statement for Dr. Sally Rockey, Â鶹´«Ã½ Deputy Director for Extramural Research

Session II

Senate

Committee on AppropriationsÌý—ÌýSubcommittee on Labor, HHS, and Education

• March 28, 2012 — Fiscal Year 2013 Budget Request for NIH
  • Written Statement for Dr. Francis Collins, Â鶹´«Ã½ Director
  • Written Statement for Dr. Anthony Fauci, NIAID Director
  • Written Statement for Dr. Richard Hodes, NIA Director
  • Written Statement for Dr. Thomas Insel, NIMH Director (testified as the Acting NCATS Director)
  • Written Statement for Dr. Griffin Rodgers, NIDDK Director
  • Written Statement for Dr. Harold Varmus, NCI Director

Committee on Environmental and Public Works-Subcommittee on Water and Wildlife

• April 24, 2012 — Legislative Hearing on Various Bills (including the Great Apes Protection and Cost Savings Act of 2011)
  • Written Statement for Dr. James Anderson, Â鶹´«Ã½ Deputy Director for Program Coordination, Planning, and Strategic Initiatives

Committee on Health, Education, Labor, and Pensions

• February 14, 2012 — Pain in America: Exploring Challenges to Relief
  • Written Statement for Dr. Lawrence Tabak, NIH Principal Deputy Director

Committee on Homeland Security and Government Affairs

• April 26, 2012 — Biological Security: The Risk of Dual-Use Research
  • Written Statement for Dr. Anthony Fauci, NIAID Director

House

Committee on AppropriationsÌý—Ìý​Subcommittee on Labor, HHS, and Education

• March 20, 2012 — Fiscal Year 2013 Budget Request for NIH
  • Written Statement for Dr. Francis Collins, Â鶹´«Ã½ Director
  • Written Statement for Dr. Thomas Insel, NIMH Director (testified as the Acting NCATS Director)

Committee on Energy and CommerceÌý—ÌýSubcommittee on Health

• June 21, 2012 — NIH: A Review of Its Reforms, Priorities, and Progress
  • Written Statement for Dr. Francis Collins, Â鶹´«Ã½ Director

Committee on Oversight and Government Reform

• December 12, 2012 — HGH Testing in the NFL: Is the Science Ready?
  • Written Statement for Dr. Lawrence Tabak, NIH Principal Deputy Director
• November 29, 2012 — 1 in 88 Children: A Look into the Federal Response to Rising Rates of Autism
  • Written Statement for Dr. Alan Guttmacher, NICHD Director

Committee on Science, Space, and Technology-Subcommittee on Investigations and Oversight and the Committee on Small Business-Subcommittee on Healthcare and Technology (joint hearing)

• April 25, 2012 — How the Report on Carcinogens Uses Science to Meet Its Statutory Obligations, and Its Impact on Small Business Jobs
  • Written Statement for Dr. Linda Birnbaum, NIEHS Director